Join the club for FREE to access the whole archive and other member benefits.

Has Metformin received too much of an attention as an anti ageing drug?


Key points from article :

Although current research gives promise to metformin as an anti-aging drug, there are still concerns.

Changes in dosage turning the result from life-extending to life-ending.

About 25% of patients treated with metformin have gastrointestinal side effects.

Chronic use causes vitamin B12 deficiency.

Gender influences drug effectiveness.

Metformin in Longevity Study (MILES) - 14 people aged >70 randomised to take metformin for 6 weeks. Glucose Lowering In Non-diabetic hyperglycaemia Trial (GLINT) will evaluate the performance of metformin in reducing CVD risks

The Targeting Aging with Metformin (TAME) trial - designed to enrol 3000 subjects.

Test whether metformin delays age-related diseases.

The TAME trial may make metformin the first approved drug for anti-aging.

The shift in the notion of aging will enable future anti-aging clinical to trials proceed with much more ease.

Studies show promise with metformin - tiny positive outcomes with side effects